Brind.

Kevin Quick was appointed Vice President of Platforms, Life Sciences at Revvity.

1 report, 1 independent Updated Sep 2

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

RevvityKevin Quick

Keep exploring

The entities involved

Revvity
American biotech company
- Revvity and Codexis, both healthcare companies, are currently competing against each other for market share.Sun 08:23
- Dovish remarks made on September 3, 2025, eased market concerns regarding high interest rates, involving the FED and Jerome Powell.Sun 01:44

Coverage

Newest first; wire copies grouped

Sep 2Business WireRevvity Establishes In Vivo Imaging Center of Excellence in North Carolina Facility designed to advance the next generation of imaging systems WALTHAM, Mass., September 02, 2025--(BUSINESS WIRE)--Rev